On the fifth anniversary of the landmark 2009 law granting the FDA authority over tobacco products, 10 leading public health and medical organizations called on the FDA and the Obama Administration to prioritize three actions to reduce tobacco use.
FDA approved a new use for Lymphoseek (technetium 99m tilmanocept) Injection, a radioactive diagnostic imaging agent, to determine the extent squamous cell carcinoma has spread in the body's head and neck region.
Grants and Intramural Program ReviewCouple of things about grants; everyone wants to know what's happening with grants.
Varmus's Joint BSA-NCAB Meeting Remarks - June 23, 2014.NCI has received some relief from sequestration, and the budget cuts will be adjusted proportionally, Director Harold Varmus said at the joint meeting of the National Cancer Advisory Board and the Board of Scientific Advisors June 23.
ODAC member Brent Logan, professor of biostatistics at the Medical College of Wisconsin, said he didn't have confidence in the PFS advantage seen in Study 19.
Some of the questions that landed the AstraZeneca drug Olaparib (lynparza) before the FDA Oncologic Drugs Advisory Committee were classic:
The Health Resources and Services Administration said it stands by its interpretation of the Affordable Care Act orphan drug exclusion, despite a recent court ruling that challenged its authority to engage in legislative rulemaking.
BALTIMORE—Constructed in Germany, shipped to the port of Baltimore, and driven through downtown during the night, the 90-ton cyclotron arrived at the University of Maryland's Proton Treatment Center.
The Cancer Letter asked David Wholley, director of the Foundation for the National Institutes of Health Biomarker Consortium, to explain the novel scientific and administrative structure of Lung-MAP.
Registration Trial DesignLung-MAP is designed to provide a fast, efficient path to full approval, said Roy Herbst, co-chair of the trial's steering committee and co-chair of its executive operations group. The idea is to get drugs to patients throughout the community, going seamlessly from a phase II portion to phase III, with all patients counting toward registration.
